I’m excited to share my executive biography, which reflects more than three decades of work in human capital strategy, nonprofit leadership, and organizational transformation. I’m currently seeking board opportunities where I can bring my passion for people, systems, and service to a mission-driven organization.

Tom Maraday is a purpose-driven executive with a legacy of transforming high-growth organizations through visionary leadership, strategic innovation, and a deep commitment to culture. With more than 30 years of experience spanning private equity, venture-backed, public, and private companies, he has consistently delivered exceptional results—scaling businesses to multimillion and billion-dollar valuations, revitalizing client success models, and pioneering commercial strategies that fuel long-term growth. Tom’s leadership is rooted in values, reflected in his dedication to mentorship, philanthropy, and organizational wellbeing, making him a trusted force in healthcare, human performance, and beyond.

I’m excited to share my updated professional biography highlighting over 25 years of experience in healthcare IT, strategic leadership, and community involvement. From founding McCormack Consultants to impactful volunteer leadership with the Boy Scouts of America, my journey continues to evolve.

Dr. Stephen M. Chang is a distinguished human geneticist with over 32 years of commercial experience in the life sciences, specializing in stem cells, cell and gene therapy, and drug development. He has co-founded multiple companies, including Orpheus Therapeutics, Legacy Therapeutics, Prometheus Therapeutics, and Princeton Drug Discovery, and serves on the boards of Orpheus Therapeutics and Histogen, Inc., where he is also Chairman and Acting CEO. Dr. Chang has held significant roles such as Vice President for Research & Development and Senior Vice President for Strategic Initiatives at the New York Stem Cell Foundation, and Chief Science Officer and Vice President at Canji Inc./Schering Plough Research Institute. His academic background includes a Ph.D. in Biological Chemistry from the University of California, Irvine, and a B.S. in Zoology, Microbiology, and Cell and Molecular Biology from the University of Michigan. Throughout his career, Dr. Chang has co-authored over 30 published papers, filed more than 15 Investigational New Drug Applications with the FDA, and is an inventor on over 50 patents worldwide. He is recognized as a pioneer in commercial gene therapy technologies and induced pluripotent stem cells, with recent successful drug developments including Adstilirin™ (rAd-IFN/Syn3) for bladder cancer therapy and Intravail™ diazepam for epilepsy treatment. Dr. Chang also serves as Entrepreneur in Residence at Rutgers University and New York University, providing strategic guidance on genetic technologies and their market applications.

: I'm excited to share my professional journey and expertise in financial management and strategic leadership within the healthcare sector. My experience reflects my commitment to excellence and continuous improvement—here is my biography.

I'm excited to share my professional journey, reflecting over 35 years of strategic leadership and advisory experience in global finance and credit origination. Now semi-retired, I'm channeling my expertise into meaningful board engagements and continued community involvement. Here is my biography.

Kris Stark is a seasoned Senior Program Manager with a proven track record of driving strategic initiatives, optimizing operations, and leading high-performing teams across both government and private sectors. With expertise in program management, risk mitigation, and organizational leadership, he has successfully managed multi-million and billion-dollar contracts, accelerated technological advancements, and improved operational efficiency for defense and cloud-based enterprises. His ability to navigate complex challenges, streamline processes, and mentor teams has consistently delivered measurable success. Holding multiple professional certifications and a Top Secret security clearance, Kris remains a forward-thinking executive dedicated to shaping the future of program management and business transformation.

Thomas Quigley is a distinguished legal executive with a proven track record in public transportation law, complex litigation, and nonprofit governance. As General Counsel of the New York Metropolitan Transportation Authority, he led a legal team of over 400 professionals, consolidated six separate legal departments, and played a key role in shaping policy alongside executive leadership and government officials. With over 25 years as a senior partner at Winston & Strawn LLP, he built a reputation as a top-tier trial lawyer and strategic advisor, handling high-stakes litigation across multiple industries. His expertise extends to compliance, risk management, corporate governance, and cybersecurity, reinforced by an M.S. in Nonprofit Management from Columbia University. Recognized by industry leaders for his legal acumen and leadership, Quigley continues to bring strategic vision and ethical leadership to every role he undertakes.

Nick Van Roijs is a results-driven executive with extensive experience in manufacturing, automotive, and business development. As CEO and General Manager of Nooyen USA, he has led strategic growth initiatives, optimizing operations and strengthening the company’s market presence. With a Master’s in Management from Nyenrode Business University and a strong foundation in strategy and innovation, he excels in business development, operational efficiency, and leadership. His diverse experience in aftersales, product management, and customer service has shaped his ability to drive sustainable success. Fluent in Dutch and English, with international expertise, Nick is a dynamic leader committed to fostering growth and innovation in the manufacturing industry.

"I'm excited to share my professional executive biography, highlighting my journey in digital health, MedTech innovation, and strategic commercialization. Over the past 15 years, I've been fortunate to lead global marketing strategies, pioneer AI-powered healthcare solutions, and drive business growth across the industry. Whether through leadership roles at Philips, Dexcom, Fitbit, and Medtronic or my advisory work with top investment firms, my focus has always been on advancing digital health solutions and patient care.

I’m excited to share my executive biography, highlighting my journey in cybersecurity, AI-driven data analytics, and national security strategy. With experience spanning defense intelligence, data integration, and leadership in AI innovation, I’m committed to enhancing decision-making processes and driving digital transformation.

Armando J. D’Errico is a seasoned executive in real estate development, construction management, and finance structuring, with over 24 years of experience leading large-scale projects and fostering economic growth. As president and CEO of Pinnacle Development Group, Inc., he has successfully developed and managed over 300,000 square feet of residential, mixed-use, and commercial real estate, specializing in affordable housing, sustainable construction, and investment structuring. A strong advocate for public-private partnerships and workforce development, he has provided job opportunities and apprenticeship programs for underprivileged youth while championing equitable urban renewal. Recognized with NJBIZ’s “40 Under 40” Award, D’Errico is also a LEED-certified professional and certified construction manager, bringing expertise in sustainability, compliance, and financial modeling. Actively seeking board roles, he aims to leverage his strategic leadership and industry expertise to drive growth, innovation, and impactful decision-making.

Adam Rynd is a seasoned business leader, entrepreneur, and investor with a proven track record of success across real estate, retail, technology, and finance. As the Owner and Designated Broker of Coldwell Banker Cascade Real Estate, he has built the firm into the premier brokerage in Central Washington, overseeing more than $300 million in annual transactions. In addition, he leads WOODIN ENTERPRISES LLC, a thriving retail business portfolio that has achieved consistent 35%+ annual revenue growth. With prior leadership roles at Salesforce and Microsoft, Adam has extensive experience in sales, contract negotiation, marketing strategy, and operational management. His ability to develop and execute strategic initiatives, combined with his commitment to innovation and community impact, has made him a driving force in every industry he operates in.

As an executive leader, board member, and private equity veteran, I have dedicated my career to optimizing executive talent, transforming leadership performance, and driving business success. Whether through executive search, leadership development, or strategic mentoring, my goal is to help businesses build best-in-class leadership teams that deliver measurable impact. Here is my biography.

I’m excited to share my executive biography, highlighting my journey in scaling healthcare businesses, driving digital transformation, and leading strategic growth initiatives. My passion lies in transforming the U.S. healthcare system through innovation, operational excellence, and strategic execution.

I'm excited to share my professional journey and expertise in digital transformation, cloud technology, and payments infrastructure. Over the past 20 years, I've passionately worked to drive growth, technology, and leadership through strategic initiatives, operational excellence, and innovation. I invite you to learn more about my experience and vision—here is my biography.